SARS-CoV-2 Parainfectious Optic Neuropathy: 3 Case Reports and a Review of the Literature

Jeffrey A Gluckstein1, Bart K Chwalisz, Aubrey L Gilbert

  • 1Neuro-ophthalmology (JAG, BKC, MAB), Massachusetts Eye and Ear, Boston, Massachusetts; Neurology (BKC), Massachusetts General Hospital, Boston, Massachusetts; Ophthalmology and Neuro-Ophthalmology (ALG), Kaiser Permanente Vallejo Medical Center, Vallejo, California; and Neuro-Ophthalmology (MAB), Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Abstract

Insights

This study defines the clinical profile of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) parainfectious optic neuritis, finding it often presents with severe vision loss and optic disc edema. Prompt steroid treatment leads to significant visual recovery in most patients.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Infectious Diseases

Background:

  • Parainfectious optic neuritis occurs after infection without direct pathogen invasion.
  • While SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) parainfectious optic neuritis cases exist, reviews with strict criteria are lacking.
  • This study aims to define the clinical profile of SARS-CoV-2 parainfectious optic neuritis.

Conclusions:

  • SARS-CoV-2 parainfectious optic neuritis presents with severe vision loss, optic disc edema, and potential bilaterality.
  • The condition responds well to corticosteroids, with significant visual recovery.
  • Further research is needed to fully characterize this clinical entity and its long-term outcomes.